Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Happel currently holds 300,000 shares of Raptor Pharmaceutical Corp (RPTP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Happel has been a net seller of RPTP stock. They have purchased $71.7K and sold $597.8K worth of shares.
David Happel's most recent insider trade was on May 28, 2026, when they sold 300,000 shares at $0.00 per share.
David Happel serves as Executive at Raptor Pharmaceutical Corp (RPTP). They have executed 13 insider transactions totaling $669.5K over their tenure at the company.
David Happel holds the position of Executive at Raptor Pharmaceutical Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
David Happel has shown a selling trading pattern, with $71.7K in total purchases and $597.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Happel was on Jul 21, 2025, when they sold $597.8K worth of SGMT shares. This transaction involved 65,478 shares at $9.13 per share.
David Happel currently owns 300,000 shares of Raptor Pharmaceutical Corp (RPTP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Happel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Happel has 13 Form 4 filings on record as an insider at Raptor Pharmaceutical Corp.
Set alerts for David Happel and 40,000+ other insiders.